MDGL
Price
$432.94
Change
+$1.72 (+0.40%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
9.61B
55 days until earnings call
VOR
Price
$1.95
Change
+$0.02 (+1.04%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
244.5M
63 days until earnings call
Interact to see
Advertisement

MDGL vs VOR

Header iconMDGL vs VOR Comparison
Open Charts MDGL vs VORBanner chart's image
Madrigal Pharmaceuticals
Price$432.94
Change+$1.72 (+0.40%)
Volume$4.68K
Capitalization9.61B
Vor Biopharma
Price$1.95
Change+$0.02 (+1.04%)
Volume$13.07K
Capitalization244.5M
MDGL vs VOR Comparison Chart in %
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. VOR commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Buy and VOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (MDGL: $431.21 vs. VOR: $1.93)
Brand notoriety: MDGL and VOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 64% vs. VOR: 52%
Market capitalization -- MDGL: $9.61B vs. VOR: $244.5M
MDGL [@Biotechnology] is valued at $9.61B. VOR’s [@Biotechnology] market capitalization is $244.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green whileVOR’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • VOR’s FA Score: 1 green, 4 red.
According to our system of comparison, both MDGL and VOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 6 TA indicator(s) are bullish while VOR’s TA Score has 3 bullish TA indicator(s).

  • MDGL’s TA Score: 6 bullish, 3 bearish.
  • VOR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MDGL is a better buy in the short-term than VOR.

Price Growth

MDGL (@Biotechnology) experienced а -1.36% price change this week, while VOR (@Biotechnology) price change was -3.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

MDGL is expected to report earnings on Oct 30, 2025.

VOR is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($9.61B) has a higher market cap than VOR($244M). VOR YTD gains are higher at: 73.874 vs. MDGL (39.745). MDGL has higher annual earnings (EBITDA): -266.74M vs. VOR (-362.82M). MDGL has more cash in the bank: 797M vs. VOR (201M). VOR has less debt than MDGL: VOR (0) vs MDGL (124M). MDGL has higher revenues than VOR: MDGL (516M) vs VOR (0).
MDGLVORMDGL / VOR
Capitalization9.61B244M3,939%
EBITDA-266.74M-362.82M74%
Gain YTD39.74573.87454%
P/E RatioN/AN/A-
Revenue516M0-
Total Cash797M201M397%
Total Debt124M0-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
27
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLVOR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAFFX86.200.90
+1.06%
American Funds Growth Fund of Amer F3
IUASX31.74N/A
N/A
VY® Invesco Equity and Income S
LAMFX24.93N/A
N/A
Lord Abbett Dividend Growth F
FSEAX60.87N/A
N/A
Fidelity Emerging Asia
JHJAX24.29N/A
N/A
JHancock ESG Large Cap Core A